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lesion (OR=2.9, CI=1.56-5.35, p=0.01) and pathologic extra
capsular lesion (OR=2.9, CI=1.05-7.90, p=0.04) were
confirmed as significant predictive factors of positive surgical
margins. Conclusion: Tumor renal site represents an important
nephrometric pre-operative characteristic predictive of PSM.
Extracapsular lesions are also correlated with a higher risk of
PSM. Mini-invasive approach seems to present lower PSM rate
for optical magnification; however, these data should be revised
assessing similar pre-operative conditions in both approaches.
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Aim: The aim of this study was to analyze gender differences
in terms of perioperative and pathological features in a
multicentre Italian dataset of patients (RECORd Project)
undergoing nephron-sparing surgery (NSS). Materials and
Methods: Overall, 1,055 patients treated with NSS, between
January 2009 and December 2012, were evaluated. An
evaluation of gender differences of pre-, intra- and
postoperative, as well as pathological variables was performed.
Results: Overall, 630 males and 346 females were analyzed.
No significant difference was found between males and
females in age at operation (analyzed as continuous and
nominal (<75 years and ≥75 years) variable), ECOG score,
clinical symptoms at diagnosis, tumor side, tumor growth
pattern and localization and, also, number of lesions at
radiological evaluation. A significant difference was found
between males and females in body mass index (BMI) (26.3
(24.7-28.4) vs. 25.3 (22.5-27.5). p<0.001), surgical indication
(relative 14.9% vs. 11.9%; absolute 8.8% vs. 3.2%,
respectively; p=0.001), pre-operative hemoglobin (14.5±1.3
vs. 13.3±1.1, p<0.001) and creatinine (1.0±0.5 vs. 0.8±0.2,
p<0.001). In intra-operative variables, no significant difference
was found between the two groups regarding surgical
approach (open vs. minimally invasive), technique (standard
partial nephrectomy vs. simple enucleation), pedicle clamping
and ischemia time. A significant difference was found between
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Table I. PSM, compared to negative surgical margins (NSM), by mean age, lesion site, approach and pathologic T.
Pre-operative data Univariate analysis Multivariate analysis
NSM PSM P OR 95%CI P
Age Mean (SD) 61.8 12.7 65.5 9.9 0.02 - - -
Indication, n. (%) Elective 748 80.3% 27 61.4% 0.002 - - -
Rel/Abs 184 19.7% 17 38.6%
Lesion site,n. % Other site 676 72.5% 20 45.5% 0.01 2.89 1.56-5.35 0.001
Polar superior 256 27.5% 24 54.5%
Approach, n. (%) Open 525 56.3% 33 86.8% 0.01 2.11 1.05-4.27 0.04
Mini-invasive 407 43.7% 5 13.2%
Pathologic T, n. % Intracapsular 894 95.9% 39 88.6% 0.02 2.89 1.05-7.90 0.04
Extracapsular 38 4.1% 5 11.4%
males and females in operative time (200 (100-300) vs. 150
(100-250) min, respectively, p=0.03) and estimated blood loss
(EBL) (135 (105-180) vs. 125 (105-160) cc, respectively,
p=0.01). A slight difference between the two groups was
found in intraoperative complication (5.8% vs. 3.2%,
respectively, p=0.07). No difference between the two groups
was found regarding overall medical, overall surgical, surgical
Clavien 2 and 3 complications. A significant difference was
found between the two groups in preoperative-1st and
preoperative-3rd day delta estimated glomerular filtration rate
(eGFR) (10.1 (0.0-23.0) vs. 12.7 (0.0-30.2), respectively,
p=0.01 and 8.5 (0.0-23.0) vs. 18.9 (0.0-30.2), respectively,
p=0.01). Regarding pathological data, a significant difference
was found between males and females relating to
malignant/benign histotype (84.1%/15.9% vs. 71.4%/28.6%,
respectively, p=0.001). Males present a 58.3% of clear cells
renal cell carcinoma (RCC) vs. 54.6% of females with a
slightly higher 3rd-4th Fuhrman grade (19.6% vs. 15.0%,
respectively, p=0.15). Conclusion: NSS in males presented a
higher intra-operative difficulty in terms of time, bleeding and
complications. Females present a higher rate of benign tumors,
as described in literature. Males present a slightly higher clear
cell RCC rate with higher Fuhrman grade.
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Introduction/Aim: Stereotactic body radiotherapy (SBRT) is
considered a safe and effective approach for several sites of
metastatic disease but few published data exist on local control
rates in the context of isolated or limited lymph node
metastases. We analyzed the outcome of oligometastatic
patients suffering from genitourinary primary neoplasms and
treated with SBRT on isolated lymph node metastases.
Materials and Methods: Patients with a maximum of 5 lymph-
nodal metastases (with a diameter of less than 5 cm) were
included in this analysis. Radiotherapy was delivered with
Volumetric Modulated Arc Therapy Rapid-Arc (VMAT-RA)
and flattening filter-free (FFF) beams; median prescribed dose
was 45 Gy in 6 fractions. We analyzed dosimetric data and
correlated them with acute toxicity (CTCAE 3.0), local control
of disease, progression-free survival and overall survival.
Results: From September 2007 to May 2015, 52 patients with
74 lymph node metastases were submitted to SBRT. Primary
malignancies were prostate (56.7%), kidney (22.9%), bladder
(19.2%), ureters (5.4%) and testicle (1.35%). At the post-
treatment re-evaluation, a complete response was achieved in
39 lesions (52.7%) and a partial response in 25 lesions
(33.7%). A stable disease was observed in 7 (9.4%) cases,
while 3 (4%) lesions showed a disease progression. The
overall clinical benefit rate was 95.8% (71/74 lesions). Acute
toxicity was mild, 18 (34.6%) patients having experienced a
G1 nausea and fatigue; no heavier toxicities were reported. At
a median follow-up of 21.8 months (range=4.2-95.6), in-field
progression of disease was observed in 12 sites (16.2%) after
a median time of 6.8 months. Out-field lymph node
progression was observed in 19 (36.5%) cases, while distant
metastases occurred in 15 (28.8%) cases. Local control and
overall survival at 1 year were 83% and 93%, respectively.
Conclusion: Our results prove that SBRT with VMAT-RA and
FFF beams can be considered a safe and effective approach
for oligometastatic patients with isolated lymph node
metastases from genitourinary tumors. Although this can be
considered an initial experience, it suggests that SBRT may be
an interesting strategy to preserve patients’ quality of life and
delay further systemic treatments.
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Introduction: Extra-adrenal paragangliomas are most commonly
found in superior para-aortic area (45%), followed by inferior
para-aortic (30%) and urinary bladder (10%), accounting for
less than 0.5% of all bladder neoplasms (1). Previous reports
show a female predominance with an age range of 32-79 years
(mean=53) and a relatively good prognosis (1, 2). There is a
documented tendency for paraganglioma of the urinary bladder
to be misinterpreted as urothelial carcinoma (1-3). We report a
case of bladder paraganglioma incidentally discovered in a
female patient and diagnosed as muscle-invasive urothelial
carcinoma. Patients and Methods: A 76-year-old woman was
admitted to our hospital after recurrent episodes of vomiting for
a hiatal hernia. A polypoid lesion of the bladder measuring 1
cm in diameter was incidentally found by computed
tomography scanning. During surgery for hiatal hernia, she
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